Infosys Profit Rises 12% as Meesho Narrows Losses in Mixed Indian Earnings Quarter
First-quarter results from major Indian corporations reveal a divergent landscape, with technology and e-commerce sectors demonstrating resilience while aviation and pharmaceuticals face margin pressures.
Indian corporate earnings for the June quarter present a mixed picture for investors, highlighting sharp contrasts between sectors. Technology and e-commerce platforms reported improved metrics, while aviation and pharmaceuticals navigated significant headwinds.
IT services major Infosys posted a 12 per cent year-on-year increase in consolidated net profit to Rs 7,769 crore, up from Rs 6,921 crore in the same period last year. Revenue from operations grew 14 per cent to Rs 48,211 crore, signaling sustained demand in global technology services.
In the e-commerce sector, Meesho narrowed its June-quarter loss to Rs 133 crore, a marked improvement from the Rs 289 crore deficit recorded a year earlier. The company attributed the better performance to sharply higher marketplace revenue, improved delivery conversion, and stronger platform monetisation.
Conversely, the aviation sector faced severe profitability challenges. Budget carrier IndiGo reported a first-quarter loss of Rs 238 crore, a stark reversal from the Rs 2,176 crore profit it achieved in the same quarter last year. Despite a 20 per cent year-on-year increase in operational revenue to Rs 24,584 crore, the airline could not offset rising sector-wide costs.
Pharmaceutical companies also delivered divergent results. Cipla saw its consolidated net profit fall 39 per cent to Rs 789 crore for the June quarter. Weakness in its North American business and compressed operating margins overshadowed record revenue generation in its domestic market.
However, Dr Reddy’s Laboratories provided a forward-looking positive signal for the pharma sector. Chief executive Erez Israeli stated that the company expects to resume supplies of its generic semaglutide by November. This follows the resolution of quality issues concerning the active pharmaceutical ingredient that previously forced a halt in shipments.
In strategic corporate developments, Wipro Consumer Care is expanding its footprint through acquisitions. The company agreed to purchase TTK Healthcare’s Good Home and Eva brands for Rs 256 crore, reinforcing a broader industry trend of using targeted buyouts to drive consumer portfolio growth.
Meanwhile, in the renewable energy space, Suzlon Energy secured a 201.6MW wind energy project order in Andhra Pradesh. The contract was awarded by Waaree Forever Energies, adding to the company’s domestic order book.
These developments underscore a complex operating environment for Indian equities. Investors will likely weigh the strong top-line growth in technology and the improving unit economics of digital marketplaces against the margin compression currently weighing on airlines and select pharmaceutical exporters.
+18
